Table 4.
Comparisons between patients receiving augmentation therapy and antipsychotic monotherapy among patients discharged on clozapine.
| Augmentation therapy n = 1374) | Antipsychotic monotherapy (n = 2874) | pa | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Sex | < 0.001 | ||||
| Male | 560 | 40.8 | 1407 | 49.0 | |
| Female | 814 | 59.2 | 1467 | 51.0 | |
| Use of anticholinergics | < 0.001 | ||||
| Yes | 665 | 48.4 | 658 | 22.9 | |
| No | 709 | 51.6 | 2216 | 77.1 | |
| Mean | SD | Mean | SD | pb | |
|---|---|---|---|---|---|
| Age (years) | 41.3 | 10.9 | 41.8 | 11.1 | 0.230 |
| Length of hospital stay (days) | 330.7 | 636.2 | 360.0 | 689.3 | 0.184 |
| Clozapine daily dose (mg) | 261.3 | 155.5 | 271.8 | 129.0 | 0.021 |
Bold, statistically significant.
aPearson’s χy2 test.
bIndependent t test.